Sergey Yurasov - Jun 10, 2022 Form 3 Insider Report for Black Diamond Therapeutics, Inc. (BDTX)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Brent Hatzis-Schoch, Attorney-in-Fact
Stock symbol
BDTX
Transactions as of
Jun 10, 2022
Transactions value $
$0
Form type
3
Date filed
6/15/2022, 04:15 PM
Next filing
Feb 15, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BDTX Stock Option (Right to Buy) Jun 10, 2022 Common Stock 250K $1.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to this option shall vest and become exercisable on June 1, 2023, with the remainder vesting in 36 equal monthly installments thereafter.

Remarks:

Exhibit 24.1 - Power of Attorney